D
Derek P. Chew
Researcher at Flinders University
Publications - 393
Citations - 21169
Derek P. Chew is an academic researcher from Flinders University. The author has contributed to research in topics: Myocardial infarction & Acute coronary syndrome. The author has an hindex of 60, co-authored 342 publications receiving 18879 citations. Previous affiliations of Derek P. Chew include Flinders Medical Centre & Auckland City Hospital.
Papers
More filters
Journal ArticleDOI
Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial)
Derek P. Chew,A. Michael Lincoff,Hitinder S. Gurm,Katherine E. Wolski,David J. Cohen,Timothy D. Henry,Frederick Feit,Eric J. Topol +7 more
TL;DR: The safety and efficacy of bivalirudin compared with heparin and planned glycoprotein IIb/IIIa inhibition in this high-risk group are comparable and consistent with the results of the overall trial.
Journal ArticleDOI
The Foundation and Launch of the Melbourne Interventional Group: A Collaborative Interventional Cardiology Project
Andrew E. Ajani,Andrew E. Ajani,Greg Szto,Stephen J. Duffy,David Eccleston,David Eccleston,David J Clark,Jeffrey Lefkovits,Derek P. Chew,Roderic Warren,Alexander Black,Gishel New,Antony Walton,R. Lew,Jonathan E. Shaw,Mark Horrigan,Martin Sebastian,Bryan P. Yan,Angela Brennan,Adam David Meehan,Christopher M. Reid,Henry Krum +21 more
TL;DR: The Melbourne Interventional Group is a voluntary collaborative venture of interventional cardiologists practicing at 12 major public and private hospitals in Victoria, designed to record data pertaining to percutaneous coronary interventions (PCI) and perform long-term follow-up.
Journal ArticleDOI
Invasive management and late clinical outcomes in contemporary Australian management of acute coronary syndromes: observations from the ACACIA registry.
Derek P. Chew,Derek P. Chew,John Amerena,Steve Coverdale,Jamie Rankin,Carolyn Astley,Ashish Soman,David Brieger +7 more
TL;DR: The impact of invasive management on 12‐month survival among patients with suspected acute coronary syndrome in Australia is described.
Journal ArticleDOI
Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction
Muayad Alasady,Walter P. Abhayaratna,Darryl P. Leong,Han S. Lim,Hany S. Abed,Anthony G. Brooks,Sue Mattchoss,Kurt C. Roberts-Thomson,Matthew I. Worthley,Derek P. Chew,Prashanthan Sanders +10 more
TL;DR: Coronary artery disease affecting the atrial branches is an independent predictor for the development of atrial fibrillation after acute myocardial infarction.
Journal ArticleDOI
Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial
Harvey D. White,Neal S. Kleiman,Kenneth W. Mahaffey,Yuliya Lokhnygina,Karen S. Pieper,Karen Chiswell,Marc Cohen,Robert A. Harrington,Derek P. Chew,John L. Petersen,Lisa G. Berdan,Philip E. Aylward,Christopher C. Nessel,James J. Ferguson,Robert M. Califf +14 more
TL;DR: The SYNERGY trial as discussed by the authors showed that enoxaparin was noninferior to UFH for the 30-day primary end point of death/myocardial infarction (MI), but modestly increased bleeding.